Unicycive Therapeutics Inc
Unicycive Therapeutics Inc (UNCY) Covered Calls
As of September 30, 2026, UNCY has 15 covered call opportunities in the coming three months. Return ranges from 9.1 to 114.1% until expiration. Annualized return ranges from 9.7 to 358.5%. The nearest expiration is October 16, 2026. Maximum potential profit is $549.
Read more
Running UNCY covered calls helps you generate consistent income from Unicycive Therapeutics Inc's shares you already own, turning a long stock position into a yield-producing asset. A covered call on Unicycive Therapeutics Inc involves holding the underlying stock and selling a call option against it, collecting premium in exchange for capping upside at the strike price. Use our scanner to find the best UNCY covered calls in real time and filter for the strikes, expiries, and premiums that fit your strategy.
A covered call is one of the most widely used options strategies because it pairs limited risk with a clear income profile: if UNCY stays below the strike at expiration, you keep the premium and the shares; if it rises above, you deliver the stock at the strike and still pocket the premium. Selling UNCY covered calls works best when implied volatility is elevated, since richer premiums improve the risk-reward. Key inputs to evaluate include strike selection relative to delta, days to expiration, annualized return, and the probability of assignment — all of which determine whether a given Unicycive Therapeutics Inc covered call is worth writing.
Unicycive Therapeutics, Inc., a biotechnology company, engages in developing novel therapies for kidney diseases in the United States. It is developing Renazorb for treatment of hyperphosphatemia in patients with chronic kidney disease; and UNI 494, for treatment of acute kidney injury. The company was incorporated in 2016 and is based in Los Altos, California.
Income-focused investors, long-term UNCY holders, and systematic premium sellers all face the same challenge: finding the covered call strike and expiry that balances yield against the risk of being called away. Our scanner ranks covered calls by annualized return, downside protection, and probability of profit, so selling UNCY covered calls becomes a measured decision instead of a guess. Stop eyeballing the chain — let the best Unicycive Therapeutics Inc covered calls come to you, already filtered for the metrics that matter.
Stock Statistics
- IndustryBiotechnology
- SectorHealthcare
- IV percentile—
- Market cap (M$)131
- 52 weeks high-46.22%
- 52 weeks low19.59%
- Analyst recommendationStrong Buy
1.00 - Target price$28.40
504.26% above the current stock price - Dividend—
- Payout ratio—
- Earnings date2026-11-11
- P/E—
- Future P/E2.56
- EPS (ttm)-1.60
- EPS growth next 5 years—
As of September 30, 2026
| 2026-11-20 | 58 | 7.50 | 55.93 | 0.05 | 0.25 | 274.00 | 56.96 | 358.48 | -1.04 | +0.18 | 622 | 0.20 |
| 2027-02-19 | 149 | 10.00 | 107.90 | 0.05 | 0.35 | 524.00 | 108.94 | 266.87 | -1.04 | +0.17 | 746 | 0.30 |
| 2027-05-21 | 240 | 10.00 | 107.90 | 0.30 | 1.20 | 549.00 | 114.14 | 173.58 | -6.24 | +0.38 | 0 | 0.90 |
| 2027-02-19 | 149 | 7.50 | 55.93 | 0.50 | 0.75 | 319.00 | 66.32 | 162.46 | -10.40 | +0.38 | 2,392 | 0.25 |
| 2026-10-16 | 23 | 5.00 | 3.95 | 0.25 | 0.40 | 44.00 | 9.15 | 145.17 | -5.20 | +0.47 | 494 | 0.15 |
| 2027-05-21 | 240 | 7.50 | 55.93 | 0.60 | 2.15 | 329.00 | 68.40 | 104.02 | -12.47 | +0.56 | 0 | 1.55 |
| 2026-11-20 | 58 | 5.00 | 3.95 | 0.45 | 0.75 | 64.00 | 13.31 | 83.73 | -9.36 | +0.53 | 411 | 0.30 |
| 2028-01-21 | 485 | 10.00 | 107.90 | 0.05 | 4.10 | 524.00 | 108.94 | 81.99 | -1.04 | +0.65 | 100 | 4.05 |
| 2027-02-19 | 149 | 5.00 | 3.95 | 0.90 | 1.40 | 109.00 | 22.66 | 55.51 | -18.71 | +0.61 | 1,257 | 0.50 |
| 2029-01-19 | 849 | 10.00 | 107.90 | 0.05 | 4.30 | 524.00 | 108.94 | 46.84 | -1.04 | +0.67 | 0 | 4.25 |
As of September 30, 2026
Sell covered calls with the data behind you
Find the best UNCY covered call setups ranked by annualized return, filter by premium, delta, and days to expiration, and act on the opportunity in seconds.
Start your 14-day free trial→